ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 145 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $195,396 | -32.3% | 28,525 | +2.5% | 0.00% | – |
| Q2 2023 | $288,711 | -66.6% | 27,841 | -73.9% | 0.00% | -100.0% |
| Q1 2023 | $863,655 | -48.6% | 106,756 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $1,681,407 | +0.1% | 106,756 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,680,339 | +435.1% | 106,756 | +375.1% | 0.00% | +100.0% |
| Q2 2022 | $314,000 | -9.0% | 22,469 | +12.3% | 0.00% | 0.0% |
| Q1 2022 | $345,000 | +18.6% | 20,008 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $291,000 | -18.0% | 20,008 | +1.3% | 0.00% | 0.0% |
| Q3 2021 | $355,000 | +17.9% | 19,743 | +15.2% | 0.00% | 0.0% |
| Q2 2021 | $301,000 | +1670.6% | 17,142 | +4.0% | 0.00% | – |
| Q1 2020 | $17,000 | -45.2% | 16,490 | 0.0% | 0.00% | – |
| Q4 2019 | $31,000 | +106.7% | 16,490 | +16.2% | 0.00% | – |
| Q3 2019 | $15,000 | -51.6% | 14,187 | 0.0% | 0.00% | – |
| Q2 2019 | $31,000 | -63.5% | 14,187 | 0.0% | 0.00% | – |
| Q1 2019 | $85,000 | -19.0% | 14,187 | 0.0% | 0.00% | – |
| Q4 2018 | $105,000 | -36.4% | 14,187 | +25.1% | 0.00% | – |
| Q3 2018 | $165,000 | -27.0% | 11,341 | 0.0% | 0.00% | – |
| Q2 2018 | $226,000 | -7.0% | 11,341 | +15.1% | 0.00% | -100.0% |
| Q4 2017 | $243,000 | -4.3% | 9,852 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $254,000 | +2.8% | 9,852 | +8.4% | 0.00% | 0.0% |
| Q2 2017 | $247,000 | – | 9,090 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |